The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications

A tétel rövid nézete
dc.contributor.authorKovács Máté Balázs
dc.contributor.departmentÁltalános Orvostudományi Karhu
dc.date.accessioned2023-06-22T21:33:50Z
dc.date.available2023-06-22T21:33:50Z
dc.date.issued2023-06
dc.identifier.urihttps://hdl.handle.net/2437/356691
dc.titleThe Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications
Fájlok
Gyűjtemények
DETEP ÁOK